Pharma Container Filling Layout With External Sterile Preparation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional pharmaceutical container production facilities require extensive and time-consuming preparatory measures for achieving high-quality cleanroom conditions, which are prone to contamination risks and disruptions, especially due to the complexity of integrating and sterilizing large components like sorting apparatuses and closure elements.

Innovation Solution

A system and method that decouples preparatory steps from the production facility by using a controllable robotic handling device and portable metering device, allowing external sterilization and decontamination, and integrating a production facility with a filling and closing station, reducing the risk of contamination and optimizing the production process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional facilities use extensive preparatory measures including cleaning, decontamination with H2O2 steam, and sterilization to achieve high cleanroom class (GMP A), then the hygiene requirements are met, but the production time is significantly increased and contamination risks remain

Engineering Contradiction:
Improvehygiene requirement fulfillmentVSAvoidproduction preparation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The production facility is divided into multiple isolated processing rooms (first processing room for filling, second processing room for closing) that can be independently prepared and sterilized. This segmentation allows parallel processing and reduces the total time required compared to sterilizing one large integrated facility, while maintaining GMP A standards in each room through targeted decontamination measures.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A robotic handling device serves as an intermediary between processing rooms, transferring containers without requiring human entry through glove ports. This eliminates a major contamination risk point and allows automated operation once preparation is complete, reducing the need for extensive re-preparation between batches and minimizing production approval delays.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If large components like sorting apparatuses with pots for closure elements and sorting tracks are integrated into the production facility, then the production capability is enhanced, but the sterilization difficulty and contamination risk increase

Engineering Contradiction:
Improveproduction capabilityVSAvoidsterilization complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The sorting apparatus for closure elements is extracted from the main production facility and positioned outside the sterile processing rooms. Closure elements are transferred into the second processing room through sealed transfer openings, separating the complex sorting function from the sterile environment. This extraction eliminates the sterilization complexity associated with large sorting apparatuses while maintaining production capability through controlled material transfer.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system is designed to handle closure elements in a manner that allows for disposable or easily replaceable components in the transfer path. Rather than attempting to sterilize complex sorting tracks and pots, the design accepts that these components may be replaced or disposed of, simplifying the sterilization requirements for the critical sterile zones while maintaining adaptability for different production needs.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of operation

If manual operations are performed via glove ports for component integration and malfunction resolution, then the operational flexibility is maintained, but the contamination risk and production disruptions increase

Engineering Contradiction:
Improveoperational flexibilityVSAvoidcontamination risk
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The robotic handling device is equipped with sensors and control systems that allow it to autonomously detect malfunctions and resolve issues without human intervention. The device can identify problems in the transfer mechanism, adjust its operations, and continue functioning, eliminating the need for manual access through glove ports. This self-service capability maintains operational flexibility while completely eliminating contamination risks associated with human entry into sterile rooms.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

Manual mechanical operations through glove ports are replaced with an automated robotic system that uses sensors, motors, and control electronics. The robotic handling device performs all transfer operations, malfunction detection, and resolution tasks that previously required human operators, substituting mechanical-human interaction with automated mechanical systems. This substitution eliminates contamination pathways while maintaining full operational capability.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS20260054868A1System for processing pharmaceutical containers and method for operating such a system
Publication Date: 2026.02.26 BAUSCH STROEBEL MASCHINENFABRIK ILSHOFEN GMBH CO KG
  • US20260054868A1 patent drawing
  • US20260054868A1 patent drawing
  • US20260054868A1 patent drawing

AI summary

A system and method for processing pharmaceutical containers includes at least one production facility for filling and closing the containers in at least one processing room and at least one preparation device which is or can be arranged spatially remote from the at least one production facility. At least one transportable container device can be docked to the production facility for introducing pharmaceutical production material which comprises the containers and closure elements. The container device can be docked to the preparation device to receive the production material. A metering device can be docked to the production facility in order to insert a filling needle and a fluid conduit.